COST-EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATE TO SEVERE ALZHEIMER'S DISEASE IN NORWAY

被引：1
|
作者：
Toumi, M. [1 ]
Lamure, M. [1 ]
Grishchenko, M. [2 ]
Cochran, J. [2 ]
Rive, B. [1 ]
机构：
[1] Univ Lyon 1, F-69622 Villeurbanne, France
[2] Lundbeck SAS, Paris, France
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74819-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A370 / A370
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of memantine in moderate and severe Alzheimer's disease in Norway
    Rive, B.
    Aarsland, D.
    Grishchenko, M.
    Cochran, J.
    Lamure, M.
    Toumi, M.
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 27 (06) : 573 - 582
  • [2] Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands
    Hoogveldt, Bart
    Rive, Benoit
    Severens, Johan
    Maman, Khaled
    Guilhaume, Chantal
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 313 - 317
  • [3] Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)
    Knapp, Martin
    King, Derek
    Romeo, Renee
    Adams, Jessica
    Baldwin, Ashley
    Ballard, Clive
    Banerjee, Sube
    Barber, Robert
    Bentham, Peter
    Brown, Richard G.
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Johnson, Tony
    Jones, Robert
    Katona, Cornelius
    Lindesay, James
    Macharouthu, Ajay
    McKeith, Ian
    McShane, Rupert
    O'Brien, John T.
    Phillips, Patrick P. J.
    Sheehan, Bart
    Howard, Robert
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32 (12) : 1205 - 1216
  • [4] Cost-effectiveness of memantine compared with standard care in moderate-to-severe Alzheimer disease in Canada
    Gagnon, Micheline
    Rive, Benoit
    Hux, Margaret
    Guilhaume, Chantal
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2007, 52 (08): : 519 - 526
  • [5] Cost effectiveness of memantine in the treatment of moderately severe and severe Alzheimer's disease in Spain
    Antonanzas, F
    Badenas, J
    François, C
    Guilhaume, C
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 765 - 765
  • [6] Cost-effectiveness of memantine in moderate-tosevere Alzheimer's disease patients receiving donepezil
    Weycker, Derek
    Taneja, Charu
    Edelsberg, John
    Erder, M. Haim
    Schmittc, Frederick A.
    Setyawan, Juliana
    Oster, Gerry
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1187 - 1197
  • [7] A systematic review of the clinical and cost-effectiveness of memantine in patients with moderately severe to severe Alzheimer's disease
    Kirby, Joanna
    Green, Colin
    Loveman, Ennna
    Clegg, Andrew
    Picot, Joanna
    Takeda, Andrea
    Payne, Elizabeth
    [J]. DRUGS & AGING, 2006, 23 (03) : 227 - 240
  • [8] Responders to memantine treatment in moderate to severe Alzheimer's disease
    Stöffler, A
    Ferris, SH
    Wirth, Y
    Reisberg, B
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S212 - S212
  • [9] A Systematic Review of the Clinical and Cost-Effectiveness of Memantine in Patients with Moderately Severe to Severe Alzheimer’s Disease
    Joanna Kirby
    Colin Green
    Emma Loveman
    Andrew Clegg
    Joanna Picot
    Andrea Takeda
    Elizabeth Payne
    [J]. Drugs & Aging, 2006, 23 : 227 - 240
  • [10] Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
    Lopez-Bastida, Julio
    Hart, Warren
    Garcia-Perez, Lidia
    Linertova, Renata
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (02) : 399 - 407
12345